165 related articles for article (PubMed ID: 35675421)
21. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.
Schimmel L; Khandekar VS; Martin KJ; Riera T; Honan C; Shaw DG; Kaddurah-Daouk R
Anticancer Res; 1996; 16(1):375-80. PubMed ID: 8615639
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.
Dolder M; Walzel B; Speer O; Schlattner U; Wallimann T
J Biol Chem; 2003 May; 278(20):17760-6. PubMed ID: 12621025
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
24. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.
Li Q; Liu M; Sun Y; Jin T; Zhu P; Wan X; Hou Y; Tu G
J Exp Clin Cancer Res; 2021 May; 40(1):168. PubMed ID: 33990217
[TBL] [Abstract][Full Text] [Related]
25. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia.
Turner DM; Walker JB
Arch Biochem Biophys; 1985 May; 238(2):642-51. PubMed ID: 3994395
[TBL] [Abstract][Full Text] [Related]
26. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
[TBL] [Abstract][Full Text] [Related]
27. Facile High-Performance Liquid Chromatography Mass Spectrometry Method for Analysis of Cyclocreatine and Phosphocyclocreatine in Complex Mixtures of Amino Acids.
Tao D; Leister W; Huang W; Alimardanov A; LeClair CA
J Agric Food Chem; 2019 Jun; 67(25):7190-7196. PubMed ID: 31194545
[TBL] [Abstract][Full Text] [Related]
28. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
[TBL] [Abstract][Full Text] [Related]
29. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.
Watt MJ; Clark AK; Selth LA; Haynes VR; Lister N; Rebello R; Porter LH; Niranjan B; Whitby ST; Lo J; Huang C; Schittenhelm RB; Anderson KE; Furic L; Wijayaratne PR; Matzaris M; Montgomery MK; Papargiris M; Norden S; Febbraio M; Risbridger GP; Frydenberg M; Nomura DK; Taylor RA
Sci Transl Med; 2019 Feb; 11(478):. PubMed ID: 30728288
[TBL] [Abstract][Full Text] [Related]
30. Cyclocreatine inhibits the production of neutrophil chemotactic factors from isolated hearts.
Elgebaly SA; Allam ME; Rossomando EF; Cordis GA; Forouhar F; Farghaly A; Kreutzer DL
Am J Pathol; 1990 Nov; 137(5):1233-41. PubMed ID: 2240167
[TBL] [Abstract][Full Text] [Related]
31. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks.
Kale VP; Wallery J; Novak J; Gibbs S; Bourdi M; Do MT; McKew JC; Terse PS
Regul Toxicol Pharmacol; 2020 Nov; 117():104750. PubMed ID: 32745584
[TBL] [Abstract][Full Text] [Related]
33. Cyclocreatine accumulation leads to cellular swelling in C6 glioma multicellular spheroids: diffusion and one-dimensional chemical shift nuclear magnetic resonance microscopy.
Schiffenbauer YS; Tempel C; Abramovitch R; Meir G; Neeman M
Cancer Res; 1995 Jan; 55(1):153-8. PubMed ID: 7805026
[TBL] [Abstract][Full Text] [Related]
34. A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer.
Samadaian N; Salehipour P; Ayati M; Rakhshani N; Najafi A; Afsharpad M; Yazarlou F; Modarressi MH
Pathol Res Pract; 2018 Dec; 214(12):2018-2024. PubMed ID: 30301636
[TBL] [Abstract][Full Text] [Related]
35. Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Cacciante F; Gennaro M; Sagona G; Mazziotti R; Lupori L; Cerri E; Putignano E; Butt M; Do MT; McKew JC; Alessandrì MG; Battini R; Cioni G; Pizzorusso T; Baroncelli L
Sci Rep; 2020 Oct; 10(1):18361. PubMed ID: 33110151
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.
Ara G; Gravelin LM; Kaddurah-Daouk R; Teicher BA
In Vivo; 1998; 12(2):223-31. PubMed ID: 9627806
[TBL] [Abstract][Full Text] [Related]
37. Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate.
LoPresti P; Cohn M
Biochim Biophys Acta; 1989 Oct; 998(3):317-20. PubMed ID: 2804134
[TBL] [Abstract][Full Text] [Related]
38. Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs.
Wiseman RW; Kushmerick MJ
J Biol Chem; 1995 May; 270(21):12428-38. PubMed ID: 7759484
[TBL] [Abstract][Full Text] [Related]
39. Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine.
Martin KJ; Vassallo CD; Teicher BA; Kaddurah-Daouk R
Anticancer Drugs; 1995 Jun; 6(3):419-26. PubMed ID: 7670140
[TBL] [Abstract][Full Text] [Related]
40. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
